Takahashi Y, Eguchi T, Bains S, Adusumilli PS. Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy. Ann Transl Med. 2016 Feb;4(4):66. - Stand Up To Cancer

Blog

Posted September 19, 2019

Takahashi Y, Eguchi T, Bains S, Adusumilli PS. Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy. Ann Transl Med. 2016 Feb;4(4):66.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.